Prolonged efficacy of sotatercept in pulmonary arterial hypertension demonstrated

被引：0
|
作者：
Lichert, Frank
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 07期
关键词：
D O I：
10.1055/a-2039-7782
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [21] Pulmonary Arterial Hypertension and TGF-β Superfamily Signaling: Focus on Sotatercept
    Stump, Benjamin
    Waxman, Aaron B.
    BIODRUGS, 2024, 38 (06) : 743 - 753
  • [22] Sotatercept in pulmonary hypertension and beyond
    Madonna, Rosalinda
    Ghelardoni, Sandra
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025,
  • [23] Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
    Sachindra R. Joshi
    Jun Liu
    Troy Bloom
    Elif Karaca Atabay
    Tzu-Hsing Kuo
    Michael Lee
    Elitza Belcheva
    Matthew Spaits
    Rosa Grenha
    Michelle C. Maguire
    Jeffrey L. Frost
    Kathryn Wang
    Steven D. Briscoe
    Mark J. Alexander
    Brantley R. Herrin
    Roselyne Castonguay
    R. Scott Pearsall
    Patrick Andre
    Paul B. Yu
    Ravindra Kumar
    Gang Li
    Scientific Reports, 12
  • [24] Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
    Joshi, Sachindra R.
    Liu, Jun
    Bloom, Troy
    Atabay, Elif Karaca
    Kuo, Tzu-Hsing
    Lee, Michael
    Belcheva, Elitza
    Spaits, Matthew
    Grenha, Rosa
    Maguire, Michelle C.
    Frost, Jeffrey L.
    Wang, Kathryn
    Briscoe, Steven D.
    Alexander, Mark J.
    Herrin, Brantley R.
    Castonguay, Roselyne
    Pearsall, R. Scott
    Andre, Patrick
    Yu, Paul B.
    Kumar, Ravindra
    Li, Gang
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [25] SOTATERCEPT FOR PULMONARY ARTERIAL HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Naeem, Hamza
    Tarar, Rameez Akram
    Ganiyani, Mohammad Arfat
    Umar, Muhammad Faiq
    Ayub, Shayan
    Anwar, Amar
    Rashid, Zayed
    Irfan, Arslan
    Cheema, Huzaifa Ahmad
    Naeem, Ahsan
    Akram, Sarah
    Javed, Abdullah
    Ahmad, Shahzaib
    Rehman, Zia Ur
    Hashmi, Arsalan
    CHEST, 2024, 166 (04) : 5804A - 5805A
  • [26] Recurrent Gastrointestinal Bleeding in a Patient With Pulmonary Arterial Hypertension Treated With Sotatercept
    Hakim, Aaron
    Fricker, Zachary P.
    Feuerstein, Joseph D.
    Farber, Harrison W.
    Schoenberg, Noah C.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (01) : 115 - 117
  • [27] Impact of Delaying Access to Sotatercept on Patients Living With Pulmonary Arterial Hypertension
    Mclaughlin, V. V.
    Alsumali, A.
    Lui, R.
    Martinez, E. C.
    Nourhussein, I.
    Klok, R.
    David, B.
    Chevure, J.
    Pena, J. de Oliveira
    Lautsch, D.
    Hoeper, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [28] Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension
    Benincasa, Giuditta
    Strozziero, Maria Grazia
    Trama, Ugo
    Napoli, Claudio
    HEART LUNG AND CIRCULATION, 2024, 33 (01): : 12 - 13
  • [29] Redefining Pulmonary Arterial Hypertension Treatment: Sotatercept's FDA Priority Review
    Kumar, Harendra
    Dhali, Arkadeep
    Biswas, Jyotirmoy
    Dhali, Gopal Krishna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [30] FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (05) : 327 - 327
12345